Related Experiment Videos
Who Should Receive Which Selective Estrogen Receptor Modulator for Prevention of Breast Cancer?
1University of Kansas Medical Center, Kansas City, Kansas.
The Breast Journal
|May 12, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
RISE UP for breast cancer 2024: conference highlights & takeaways.
Breast cancer research and treatment·2026
Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008).
Obesity (Silver Spring, Md.)·2018
Change in Physical Activity During a Weight Management Intervention for Breast Cancer Survivors: Association with Weight Outcomes.
Obesity (Silver Spring, Md.)·2017
Is Neoadjuvant Chemotherapy Necessary for Male Breast Cancer? A SEER-Based Population Study.
The breast journal·2026
An Algorithm for Salvage of Implant-Threatening Complications in Breast Reconstruction.
The breast journal·2026
The 5-Lipoxygenase Pathway in Ovarian Cancer: Mechanisms of Metastasis, Chemoresistance, and Translational Targeting.
International journal of women's health·2026
Dual Targeting of CXCR4 and CXCL12 by 1,2,4-Triazole Derivatives: A Computational Approach Against Lung Cancer Metastasis.
Iranian journal of pharmaceutical research : IJPR·2026
ALDH1A3 Inhibition by Prosopis farcta Phytochemicals: A Computational Exploration of a Potential Antidiabetic Mechanism.
Iranian journal of pharmaceutical research : IJPR·2026
Lyoniresinol Improves Insulin Sensitivity and Induces White-to-Beige Adipose Tissue Conversion in Obese Rats: Associated with JNK/PI3K/mTOR Pathway Modulation.
Iranian journal of pharmaceutical research : IJPR·2026